Ki Hwan Son

Title: Ki Hwan Son: Innovator in Fibrin Sealant Technology

Introduction

Ki Hwan Son is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of fibrin sealants. His innovative approach has the potential to enhance surgical procedures and patient outcomes.

Latest Patents

Ki Hwan Son holds a patent for a "Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof." This method involves adding amino acids or amino acid derivatives, and/or salts to a lowly concentrated fibrinogen solution, followed by ultra-filtration concentration. The process allows for the creation of a fibrin sealant component that can be preserved at room temperature and used without reconstitution. This innovation is crucial for providing effective medical solutions in various surgical applications.

Career Highlights

Ki Hwan Son is associated with Green Cross Holdings Corporation, where he continues to work on advancements in medical technology. His expertise in fibrin sealant development has positioned him as a key figure in the industry. His work not only reflects his dedication to innovation but also his commitment to improving healthcare solutions.

Collaborations

Ki Hwan Son has collaborated with notable colleagues, including Jun Sic Kim and Gun Sul Lee. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical technology.

Conclusion

Ki Hwan Son's contributions to fibrin sealant technology exemplify the impact of innovation in healthcare. His patented methods and ongoing work at Green Cross Holdings Corporation highlight the importance of advancements in medical solutions. His efforts are paving the way for improved surgical practices and patient care.